Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
C. Bolden-Watson, E. Richelson
Neuroscience
Research output
:
Contribution to journal
›
Article
›
peer-review
400
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Biogenic Amines
84%
Synaptosomes
78%
Sertraline
63%
femoxetine
63%
Lofepramine
59%
Antidepressive Agents
58%
Atomoxetine Hydrochloride
47%
Paroxetine
41%
etoperidone
33%
desmethylsertraline
31%
Brain
31%
norfluoxetine
27%
Serotonin
27%
Norepinephrine
27%
Dopamine
27%
nefazodone
25%
Venlafaxine Hydrochloride
21%
Carbamazepine
18%
Drug Interactions
15%
Frontal Lobe
15%
Pharmaceutical Preparations
13%
Hippocampus
12%
Chemical Compounds
Sertraline
100%
Femoxetine
91%
Lofepramine
87%
Antidepressant
81%
Paroxetine
64%
Etoperidone
44%
Dopamine
40%
Nefazodone
40%
Venlafaxine
33%
Antidepressant Agent
29%
Carbamazepine
26%
Metabolite
15%
Drug
11%